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Midkine induces the transformation of NIH3T3 cells
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Summary Midkine (MK) is a heparin-binding growth factor and is frequently expressed at high levels in many human carcinomas. To
investigate further the roles of MK in the regulation of cell growth, we introduced MK expression in NIH3T3 cells. A mixture of transfectants of
an MK expression vector, but not a control vector, formed colonies in soft agar, showed an elevated cell number at confluence, and formed
tumours in nude mice. An interesting characteristic of the transformed cells was that they became spontaneously detached from the culture
dish substratum. In the transformed cells, MK was not only secreted, but also localized, in the perinuclear region as spots. The present data
indicate that MK has the potential to transform NIH3T3 cells and suggest that overexpression of the MK gene may promote unregulated cell
growth in vivo.
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Polypeptide growth factors play regulatory roles in the develop-
ment and maintenance of normal tissues and also contribute to
the processes of transformation and tumorigenesis in vivo (Cross
and Dexter, 1991). Midkine (MK), originally isolated as a product
of a retinoic acid-responsive gene in an embryonal carcinoma
cell differentiation system, is a heparin-binding growth factor
(Kadomatsu et al, 1988; Tomomura et al, 1990 a,b) implicated in
neuronal survival and differentiation (Muramatsu and Muramatsu,
1991; Michikawa et al, 1993; Unoki et al, 1994), carcinogenesis
(Tsutsui et al, 1993; Nakagawara et al, 1995), fibrinolysis (Kojima
et al, 1995), wound healing (Yoshida et al, 1995) and development
(Kadomatsu et al, 1990; Mitsiadis et al, 1995a, b). MK belongs
to a novel growth factor family whose only members so far
are MK and pleiotrophin (PTN)/HB-GAM (Muramatsu, 1993,
1994). MK and PTN have approximately 50% homology, with
completely conserved cysteine positions, and share several
biochemical and biological properties: heparin-binding, neuro-
trophic activity (Li et al, 1990; Merenmies and Rauvala, 1990) and
involvement in wound healing (Takeda et al, 1995) and carcino-
genesis (Chauhan et al, 1993).
Expression of MK and PTN has been investigated in many
human tumours, including meningiomas (Mailleux et al, 1992),
Wilms' tumours (Tsutsui et al, 1993), lung carcinomas (Garver et
al, 1993), breast carcinomas (Garver et al, 1994), neuroblastomas
(Nakagawara et al, 1995), gastric carcinomas, hepatic carcinomas
and colon carcinomas (Aridome et al, 1995). The expression
profiles of MK, compared with those of PTN, appear to be more
aggressive in general. For example, MK is more frequently and
abundantly expressed in Wilms' tumours (Tsutsui et al, 1993). In
the lung, MK is not expressed in normal tissues and is abundantly
expressed in the carcinomas, but PTN expression is reciprocal
(Garver et al, 1993). In neuroblastomas, PIN is expressed in early
clinical stages, and there is a reverse relationship between PTN
expression and apoorprognosis. MK expression in neuroblastomas
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is relatively constant through the whole clinical stages and is more
abundant than PTN in each stage (Nakagawara et al, 1995). On the
other hand, PTN has been reported to transform NIH3T3 cells
(Chauhan et al, 1993). Ribozyme-mediated PTN RNA disruption
results in a loss of tumorigenecity of WM852 cells (a human
melanoma cell line) (Czubayko et al, 1994).
In addition to the preferential expression in human tumours,
MK provides growth advantages to some cells: MK enhances
the proliferation of NIH3T3 cells by approximately twofold
(Muramatsu and Muramatsu, 1991), and of 1009 EC cells by
threefold at a differentiation state induced by retinoic acid
(Nurcombe et al, 1992); anti-MK antibodies partially inhibit the
proliferation of G401 cells (a Wilms' tumour cell line)
(Muramatsu et al, 1993). Taken together, all the data described
above indicate that MK could be involved in carcinogenesis, but
the biological functions of MK, essential for the process of
carcinogenesis, have not been determined. In the present study, we
focused on investigation of the activities of MK to induce cellular
transformation and tumours in nude mice.
MATERIALS AND METHODS
Cells and DNA transfection
NIH3T3 cells and ret oncogene-transformed NIH3T3 cells were
generous gifts from Dr H Takahashi (Asai et al, 1995). Both the
NIH3T3 cells and retoncogene-transformed cells were maintained
in Dulbecco's modified Eagle medium (DMEM) containing 10%
calf serum. For DNA transfection, NIH3T3 cells were plated at a
density of 3 x 105 cells in a 35-mm dish. On the following day, 10
gg ofeither MIWmMK (a mouse MK expression vector under the
control of the Raus sarcoma virus enhancer and the chicken P-
actin promoter and enhancer) or MIW (an empty vector without
any inserted cDNA) was transfected together with 1 gg ofpSTneo
(a neomycin-resistant gene expression vector) into NIH3T3 cells
by the use of lipofectin (Gibco BRL), following the manufac-
turer's instruction (for the vectors, see Tomomura et al, 1990b).
Neomycin-resistant colonies were isolated from the tissue culture
dishes after 14 days exposure to 400 ,ug ml-' G418 (Sigma),
followed by examination ofanchorage-independent growth in soft
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agar. Another way to clone MIWmMK or MIW transfectants was
that the transfected cells, after 7 days exposure to 400 ,ug ml'
G418, were grown directly in soft agar. Cells transfected with
MIWmMK, but not MIW, formed colonies in soft agar in this case.
Colonies in soft agar were cloned using Pasteur pipettes and were
used for further studies.
Soft agar assay
Cells were suspended in 2 ml oftop agar consisting of0.35% agar
in DMEM containing 20% fetal bovine serum (FBS) and were
layered on 3 ml of bottom agar (0.5% agar in DMEM containing
20% FBS) in a 35-mm dish. Colonies in soft agar were counted 14
days after plating. We first examined 1 x 105 cells for each soft
agar assay to screen the anchorage independence, and then used
1 x 103 cells, if colonies were observed, to quantify the activities
to induce anchorage-independent growth.
Nude mice studies
Cells suspended at a density of 3 x 106 in 0.3 ml of Hanks' buffer
were injected subcutaneously into one site on either the flank or
subaxillar region to examine the tumorigenicity in KSN mice.
Artificial metastasis experiments were also performed by injecting
3 x 105 cells suspended in 0.1 ml of Hanks' buffer into a tail vein
(Egan et al, 1987). Metastatic nodules in the lungs were counted, if
any, 8 weeks after the tail vein injection.
Western, Northern and Southern blot analyses
Cells were cultured in DMEM containing 10% calf serum in a 24-
well plate until the cells in each well became confluent. Once they
had become confluent, the medium was replaced with 500 gl of
DMEM containing ITS (insulin, transferrin and selenious acid at a
concentration of 5 ,ug ml' each) and 40 gg ml-1 heparin in each
well. After 4 h incubation, proteins in the ITS medium from each
well were precipitated with 10% trichloroacetic acid, followed by
further precipitation with ethanol. The ethanol precipitates were
subjected to sodium dodecyl sulphate (SDS)-polyacrylamide gel
electrophoresis. After transfer to a nitrocellulose membrane, the
MK protein was detected with anti-mouse MK antibodies (dilu-
tion, 1:1000) and horseradish peroxidase-labelled anti-rabbit IgG
(Jackson Laboratory; dilution, 1:5000) with the use of an ECL
system (Amersham). The preparation and characterization of
affinity-purified rabbit anti-mouse MK polyclonal antibodies,
which were raised against L cell-produced MK, were described
previously (Muramatsu et al, 1993). Affinity-purified rabbit poly-
clonal antibodies against bacteria-produced MK were a generous
gift from Dr S Ikematsu and worked as well as the antibodies
against cell-produced MK (see Take et al, 1994 for bacteria-
produced MK). Fibronectin expression was examined in the same
way as MK expression, using samples prepared from both ITS
medium and cell lysates (cells were directly lysed with the SDS-
PAGE sample buffer). Affinity-purified rabbit anti-human
fibronectin was a generous gift from Dr K Sekiguchi (Sekiguchi et
al, 1986). Integrin ,Bl in the cell lysates was also analysed with
rabbit anti-human integrin Pl (RM22; Bioline Diagnostici).
Northern blot and Southern blot analyses were performed as previ-
ously described (Sambrook et al, 1989). The probes for metallo-
proteases 1, 3 and 7 were generous gifts from Dr H Satoh. The
probes forbovine urokinase-type plasminogen activator (uPA) and
Table 1 Transformation by MK
Cells MK Detach Soft agar Nude mice Latency
expression (colonies
per 1000 cells)
NIH3T3 - - 0, 0 0/5 -
Control mix - - 0, 0 0/20
Control 2 - - 0, 0
Control5 - - 0, 0 0/4
Control 6 - - 0, 0
MK mix + + 351,366 24/31 4 weeks
MK 1 + + 259,257 11/18 4 weeks
MK5 + + 448, 424 10/14 4 weeks
MK8 + + 80, 81
MK 10 + + 104,103 3/3 4weeks
MK14 + - 0,0 0/4 -
MK 18 + - 0, 0 0/3
MK21 + - 1, 3 0/4 -
MK23 + - 0,1
bovine uPA receptor were generous gifts from Dr W-D Scheuning.
The probes contained the following sequences: 774 to 1970 for
MMP-l cDNA (Whithan et al, 1986), 149 to 1597 for MMP-3
cDNA (Whithan et al, 1986), the full coding sequence for MMP-7
cDNA (Muller et al, 1988) and the full coding sequence for uPA
and uPA receptor cDNA (Kratzschmar et al, 1993).
Midkine
Yeast-produced human MK was a generous gift from Dr S
Ikematsu, the neurotrophic activity ofwhich was similar to that of
L cell-produced MK (Muramatsu and Muramatsu, 1991).
Zymography
The activities of metalloproteases 2 and 9, as well as membrane-
type metalloprotease, were examined by gelatin zymography, as
previously described (Heussen and Dowdle, 1980).
Immunocytochemistry
Immunocytochemistry was performed essentially as described
previously (Baldin et al, 1990). Briefly, cells grown to subconflu-
ence on a glass coverslip were fixed with 3% paraformaldehyde in
phosphate-buffered saline (PBS) for 15 min at 4°C, following
wash with 0.1% bovine serum albumin (BSA) in PBS for 5 min at
4°C twice. After washing with 0.1% BSA in PBS for 5 min at 4°C
twice, the cells were incubated sequentially with 50 mm ammo-
nium chloride in PBS for 20 min at4°C, and 0.5% Triton X-100 in
PBS for 5 min at room temperature, and then washed sequentially
with PBS for 5 min at 4°C twice, and 0.1% BSA in PBS for 5 min
at 4°C twice. The cells were blocked with PBS/10% fetal bovine
serum in DMEM (1:1) for 30 min at room temperature and then
incubated with an affinity-purified rabbit anti-mouse MK antibody
in 0.1% BSA in PBS (1:200 dilution) overnight at 4°C. Following
washing with 0.1% BSA in PBS for 5 min at 4°C three times, the
cells were incubated with fluorescein isothiocyanate-conjugated
goat anti-rabbit IgG (1:200 dilution; Jackson Laboratories) for 30
min at room temperature. Immunofluorescence was observed on a
fluorescence microscope (Olympus, Model BX60) after washing
with 0.1% BSA in PBS for 5 min at 4°C six times.
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Figure 1 CellRroliferation profiles of MK-mediated transformed NIH3T3 cells
(x; MK mixinWte1) and untransformed cells (E; control mix in Table 1).
Cell numbers were determined in triplicate on the indicated days after plating
cells at a density of 1 x 105 cells per 35-mm dish. Vertical bars, standard
deviations
RESULTS
Transformation of NIH3T3 cells
We first transfected either a mouse MK expression vector
(MIWmMK) or a control vector (MIW) together with pSTneo (a
neomycin-resistant gene expression vector) into NIH3T3 cells.
Colonies on tissue culture dishes were then isolated after 14 days of
G418 selection. The isolated clones from both MIWmMK and
MIW, however, showed no anchorage independence (MK14, 18,21
and 23, and control 2, 5 and 6 in Table 1). To examine further the
transforming activity of MK, we transfected the vectors with
pSTneo again and pooled the transfectants of either MIWmMK or
MIW after 7 days of G418 selection. The pooled transfectants of
MIWmMK, but not MIW, formed colonies in soft agar (MK mix
and control mix, Table 1). The growth rate of MK mix cells was
estimated after plating at a density of 1 x l05 cells per 35-mm dish
(Figure 1). MK mix cells grew faster than control mix cells and
became almost confluent atday 3,when the cell numberofMK mix
was approximately 2.5-fold relative to control mix cells. After day
3, MK mix cells still proliferated, although the growth rate became
slightly slow: the density of MK mix cells was again 2.5-fold
higher than that of control mix ones at day 4. Since the MK mix
cells started to become detached after day 4, it was impossible to
observe cell numbers and cell shapes further. MK mix cells formed
tumours in nude mice (Table 1 and Figure 3). But the transforming
activity of MK seemed to be relatively weak, as it took 4 weeks to
obtain visible tumours in contrast to ret oncogene-transformed
NIH3T3 cells, in which case visible tumours were observed in 1
week (the parent NIH3T3 cells used for the ret oncogene study
were the same as those for the MK study) (data not shown).
Colonies of the pooled transfectants of MIWmMK in soft agar
were isolated and cloned using Pasteur pipettes (MK 1, 5, 8 and 10
in Table 1). The isolated clones formed colonies in soft agar and
formed tumours in nude mice (MK 1, 5, 8 and 10 in Table 1).
These clones were independent, as each clone showed distinct
expression levels ofMK protein and mRNA and a distinct chromo-
somal integration pattern of MIWmMK plasmid DNA (Figure 2).
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Figure 2 Expression and chromosomal integration of the MK expression
vector. (A) MK protein expression in parent NIH3T3 cells, control vector-
transfected cells and MK expression vector-transfected cells. Each lane
corresponds to the whole medium at confluence in each well of a 24-well
plate (see Materials and methods for details). The names of the cells at the
top are the same as those in Table 1. Protein sizes are marked at the right.
(B) MK RNA expression. Total RNA (10 kg) was applied to each lane.
Ethidium bromide staining is shown at the bottom to indicate that similar
amounts of intact RNA were applied (C) Integration of the MK expression
vector. Genomic DNA (10 ,g) was digested with Hincill, which did not cut the
MlWmMK vector plasmid, and then subjected to electrophoresis. The
integration profiles of MlWmMK were determined with a 32P-labelled probe
from the MIW plasmid
MK clones from tissue culture dishes also expressed the MK
protein at similar levels (MK 14 and 18 in Figure 2A).
To assess the ability of the exogeneously added MK to induce
the anchorage-independent growth ofNIH3T3 cells, we performed
the soft agar assay, using soft agar containing MK at concentra-
tions of 0.1, 1.0, 10.0 ig ml-' with the combination of parent
NIH3T3 cells as well as control mix cells. However, no colonies
were detected in the soft agar (data not shown).
Characteristics of MK transformants
The most interesting characteristic of cells transformed with
MIWmMK was thatthey became spontaneously detached fromthe
substratum on a tissue culture dish. They started to become
detached once they became confluent, usually 5 to 6 days after
plating. In the case of clone MK 5, the most readily detaching
clone, the cells started to become detached 3-4 days after plating
even if they were not confluent. The detached cells formed cell
aggregates and were viable, because they could be maintained on
tissue culture dishes ifthe cell aggregates were replated, following
treatment with tyrosine-EDTA (Figure 3A and B). To elucidate
the mechanism of detachment, we examined the activities and
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Figure 3 Detachment and tumour formation of cells transformed with MK.
(A and B) MK-mediated transformed NIH3T3 cells became spontaneously
detached from the substratum of a tissue culture dish. It started 3 days after
plating in the case of MK5 cells (A). The detached cells formed aggregates,
an example of which is shown at the centre of (B) (C and D) MK-mediated
transformed NIH3T3 cells formed tumours in nude mice. Tumours on the left
flank and the right subaxillar region are shown in C. The tumours showed
typical histological features of fibrosarcoma. Bars = 100 gm
expression of various proteins as follows: gelatin zymography for
activities ofmetalloproteases (MMPs) 2 and 9 and membrane-type
MMP(Sato etal, 1994); Northern blotanalyses fortheexpressions
of MMPs 1, 3 and 7, urokinase-type plasminogen activator (uPA)
and uPA receptor; and Western blot analyses forthe expressions of
fibronectin and integrin ,B1. No difference, however, was observed
between the transformed and untransformed cells. To determine
whether the exogenously added MK could induce spontaneous
detachment of cells from the substratum, we cultured parent
NIH3T3 cells as well as control mix cells in the presence ofMK at
concentrations of 0.1, 1.0, 10.0 jig ml-', but we did not observe
any spontaneous detachment.
Spontaneous metastases derived from subcutaneous tumours in
nude mice were not observed in any organ, as evaluated at 10
weeks after injection of the cells. We also employed an artificial
metastasis system, in which lung metastases could be observed
after tail vein injections of cells (Egan et al, 1987). Mice were
sacrificed 8 weeks after tail vein injection, but no lung metastatic
nodules were observed.
In addition to the secreted form, MK was also detected as an
intracellular form in the transformed cells by means ofimmunocy-
tochemistry with an anti-mouse MK antibody. MK existed as spots
in quite restricted perinuclear areas (Figure 4). This profile was not
Figure 4 MK localization in the prenuclear region. An MK-mediated
transformed clone (MK 1) was stained with the combination of a rabbit anti-
mouse MK antibody and fluorescein isothiocyanate-conjugated goat anti-
rabbit IgG (see Materials and methods). (A) Nomarski
differential-interference-contrast microscopy. (B) Immunofluorescence
microscopy. Bars = 20 gm
observed ifpreimmune rabbit serum was used or ifparent NIH3T3
cells were examined.
DISCUSSION
The present study has shown that MK is a member of the growth
factors with oncogenic potential, as evidenced by three independent
criteria, i.e. an elevated cell number at confluence, anchorage-
independent growth and tumour formation in nude mice. MK has
also been reported to enhance the cell growth of an epithelial cell
line, SW 13 cells, in soft agar (Czubayko et al, 1994). In addition,
MKexpression is temporally and spatially regulatedduring embryo-
genesis: preferential MK expression is observed where epithe-
lial-mesenchymal interactions take place as well as where cells
are in proliferative states (e.g. caudal halves of sclerotomes)
(Kadomatsu et al, 1990). These data indicate that MK has the poten-
tial to play a critical role in both normal and abnormal cell growth
and suggest that overexpression of MK may promote unregulated
cell growth in vivo. We recently demonstrated that a truncated-type
MK transcript, which encodes an alternatively spliced product
lacking the 3rd exon, is expressed in tumour cell lines and tumour
specimens,but not in normal tissues (Kaname etal, 1995). The trun-
cated type, ifexpressed, is always accompanied by the mature MK
transcript. It will be interesting to determine whether or notthe trun-
cated MK modulates the behaviourofNIH3T3 cells transformed by
the mature MK and other tumour cells expressing the mature MK.
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As cells transformed by MK gain the ability to become sponta-
neously detached from the substratum, the soft agarrather than the
tissue culture dish may provide a much better environment for
obtaining MK transformants. Thus, the failure to obtain trans-
formed cells from colonies on tissue culture dishes after transfec-
tion of the MK expression vector could be attributed to the
heterogeneity of NIH3T3 cells, more specifically, probably to the
loss of MK receptor(s) or defects of intracellular pathways regu-
lated by MK in cells attached to tissue culture dishes. The
detaching characteristic suggests that overexpression of MK may
cause a disorganized cell-substratum interaction, although the
mechanism by which MK transforms NIH3T3 cells remains to be
elucidated. In general, the oncogenic effect of growth factors is
thought not to be exerted entirely through the classical route of
signalling through cell surface receptors (Cross and Dexter, 1991).
There may be at least two other important routes. First, premature
binding between growth factors and receptors present on the
internal membrane of the endoplasmic reticulum and the Golgi
apparatus may contribute to the signalling of transformation.
Second, the products of some growth factor genes may directly
regulate intranuclear events. Basic fibroblast growth factor (FGF),
platelet-derived growth factor (PDGF) and one of the int-2 prod-
ucts have been reported to be localized in the nucleus (Bouche et
al, 1987; Yeh et al, 1987; Acland et al, 1990). In the case ofbasic
FGF, it may directly regulate the transcription of ribosomal genes
(Bouche et al, 1987). The present study showed that MK was
localized in the perinuclear region as spots in addition to being
secreted. Interestingly, the exogenously added MK were able to
induce neither spontaneous detachment from the substratum nor
anchorage-independent growth in the present study. MK has also
been reported to bind to nucleolin, a shuttle protein between the
nucleus and the cytoplasm (Take et al, 1994). There is a possibility
that concerted action of the extracellular MK form and the intra-
cellular MK form is required for cellular transformation.
Diethyl nitrosamine (DEN) induces liver carcinomas in rats and
provides a good model for investigating the process of carcino-
genesis. Six weeks after DEN administration, tiny foci are
observed in the liver, which are thought to be precancerous lesions.
MK expression is observed from this point in the foci through to
terminal stages in the carcinomas (H Kanda et al, manuscript in
preparation). Both the present study and the rat livermodel suggest
that MK is involved in carcinogenesis at early stages.
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